BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24511005)

  • 1. ESR1 promoter methylation in squamous cell cervical cancer.
    Kirn V; Zaharieva I; Heublein S; Thangarajah F; Friese K; Mayr D; Jeschke U
    Anticancer Res; 2014 Feb; 34(2):723-7. PubMed ID: 24511005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Alteration by DNA Methylation of ESR1, MYOD1 and hTERT Gene Promoters is Useful for Prediction of Response in Patients of Locally Advanced Invasive Cervical Carcinoma Treated by Chemoradiation.
    Sood S; Patel FD; Ghosh S; Arora A; Dhaliwal LK; Srinivasan R
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):720-7. PubMed ID: 26344356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.
    Kirn V; Shi R; Heublein S; Knabl J; Guenthner-Biller M; Andergassen U; Fridrich C; Malter W; Harder J; Friese K; Mayr D; Jeschke U
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1681-7. PubMed ID: 24908329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of ESR1 methylation at promoter region with progression of cervical lesion in Uyghur women].
    Aliyeguli A; Abida A; He H; Abulizi A
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):765-6. PubMed ID: 23302339
    [No Abstract]   [Full Text] [Related]  

  • 5. Loss of estrogen receptor 1 enhances cervical cancer invasion.
    Zhai Y; Bommer GT; Feng Y; Wiese AB; Fearon ER; Cho KR
    Am J Pathol; 2010 Aug; 177(2):884-95. PubMed ID: 20581058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases.
    Kirn V; Strake L; Thangarajah F; Richters L; Eischeid H; Koitzsch U; Odenthal M; Fries J
    Clin Exp Metastasis; 2018 Oct; 35(7):707-712. PubMed ID: 30173322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDH1 promoter methylation in patients with cervical carcinoma: a systematic meta-analysis with trial sequential analysis.
    Liu G
    Future Oncol; 2018 Jan; 14(1):51-63. PubMed ID: 29237293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
    Bhat S; Kabekkodu SP; Varghese VK; Chakrabarty S; Mallya SP; Rotti H; Pandey D; Kushtagi P; Satyamoorthy K
    Tumour Biol; 2017 Mar; 39(3):1010428317694573. PubMed ID: 28351298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between DNA Methylation of ZNF772 Promoter Region and Cervical Cancer].
    Li M; Li O; Sun J; Zheng X; Ma D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Apr; 42(2):164-171. PubMed ID: 32385021
    [No Abstract]   [Full Text] [Related]  

  • 11. Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix.
    Lee EJ; Mcclelland M; Wang Y; Long F; Choi SH; Lee JH
    Oncol Res; 2010; 18(9):401-8. PubMed ID: 20524398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
    Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
    Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiation therapy induces
    Sood S; Patel FD; Srinivasan R; Dhaliwal LK
    Indian J Med Res; 2018 Feb; 147(2):151-157. PubMed ID: 29806603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of the VIM promoter in uterine cervical squamous cell carcinoma.
    Lee MK; Jeong EM; Kim JH; Rho SB; Lee EJ
    Oncology; 2014; 86(5-6):359-68. PubMed ID: 24942637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of the RASSF1A gene promoter in Uigur women with cervical squamous cell carcinoma.
    Pan Z; Li J; Pan X; Chen S; Wang Z; Li F; Qu S; Shao R
    Tumori; 2009; 95(1):76-80. PubMed ID: 19366060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative p16 and ESR1 methylation in the peripheral blood of patients with non-small cell lung cancer.
    Suga Y; Miyajima K; Oikawa T; Maeda J; Usuda J; Kajiwara N; Ohira T; Uchida O; Tsuboi M; Hirano T; Kato H; Ikeda N
    Oncol Rep; 2008 Nov; 20(5):1137-42. PubMed ID: 18949413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
    Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
    Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA.
    Sheng X; Guo Y; Lu Y
    Medicine (Baltimore); 2017 Jul; 96(28):e7476. PubMed ID: 28700487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.
    Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G
    Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.